SUN bioscience is the first company to standardize organoid cultures. Organoids are mini-organs grown from stem cells with potential from personalized drug screening to transplants. Our first focus is to bring retinal organoids to clinics with the long-term goal to transplant photoreceptors for retinal degeneration, a set of diseases with neither treatments nor cures. While establishing the GMP protocols, we service pharmaceutical companies for their drug screening needs.
Connect with SUN bioscience